Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H11NO2 |
| Molecular Weight | 189.2105 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)CC(C1=O)C2=CC=CC=C2
InChI
InChIKey=WLWFNJKHKGIJNW-UHFFFAOYSA-N
InChI=1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3
| Molecular Formula | C11H11NO2 |
| Molecular Weight | 189.2105 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://www.drugbank.ca/drugs/DB00832Curator's Comment: description was created based on several sources, including:
http://www.druglib.com/activeingredient/phensuximide/
Sources: http://www.drugbank.ca/drugs/DB00832
Curator's Comment: description was created based on several sources, including:
http://www.druglib.com/activeingredient/phensuximide/
Phensuximide is an anticonvulsant in the succinimide class. For the treatment of epilepsy. Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex. Phensuximide's mechanism of action not understood, but may act in inhibitory neuronal systems that are important in the generation of the three per second rhythm. It's effects may be related to its ability to inhibit depolarization-induced accumulation of cyclic AMP and cyclic GMP in brain tissue.
Originator
Approval Year
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
7.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/116142/ |
20 mg single, oral dose: 20 mg route of administration: Oral experiment type: SINGLE co-administered: |
PHENSUXIMIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Urinary tract effects of phensuximide in the Sprague-Dawley and Fischer 344 rat. | 1986-10 |
|
| Inhibitory effects of anticonvulsant drugs on cyclic nucleotide accumulation in brain. | 1979-06 |
|
| Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide. | 1963-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:19 GMT 2025
by
admin
on
Mon Mar 31 17:58:19 GMT 2025
|
| Record UNII |
6WVL9C355G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
WHO-VATC |
QN03AD02
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
WHO-ATC |
N03AD02
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
513
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
PHENSUXIMIDE
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
m8643
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
201-664-6
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
34367-67-4
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
SUPERSEDED | |||
|
100000082262
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
C66375
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
86-34-0
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
6WVL9C355G
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
DTXSID4023460
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
33309
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB09783MIG
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
2139
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL797
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
1528002
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
6839
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
DB00832
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
760079
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
C100129
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |